drugset / Trial / NCT00759577

Feasibility of "At-home" Titration of Solifenacin

NCT00759577

Phase 4 Terminated 36 enrolled NYU Langone Health
NaSingle-groupOpen-labelTreatment

Summary

This is an open-label single center trial to study improvements in symptom bother and quality of life in overactive bladder patients self titrating solifenacin 5mg and 10 mg. The study is designed to reflect real world conditions in typical male and female OAB patients presenting for treatment.

Timeline

Start
2008-09
Primary completion
2010-05
Completion
2010-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Solifenacin Small molecule 5 mg Oral
Subject Solifenacin Small molecule 10 mg Oral

Indications